Defiance Daily Target 2X Long HIMS ETF (NASDAQ:HIMZ – Get Free Report) was the recipient of a significant decline in short interest in the month of October. As of October 15th, there was short interest totaling 403,886 shares, a decline of 50.8% from the September 30th total of 820,318 shares. Approximately 16.4% of the shares of the company are short sold. Based on an average daily trading volume, of 395,070 shares, the days-to-cover ratio is currently 1.0 days.
Defiance Daily Target 2X Long HIMS ETF Stock Down 13.7%
Shares of NASDAQ:HIMZ traded down $3.54 during midday trading on Friday, reaching $22.31. 358,209 shares of the company traded hands, compared to its average volume of 1,062,917. Defiance Daily Target 2X Long HIMS ETF has a 12 month low of $12.38 and a 12 month high of $201.60. The firm has a market capitalization of $53.10 million, a price-to-earnings ratio of 137.04 and a beta of 4.13. The firm’s fifty day moving average price is $26.38 and its two-hundred day moving average price is $33.24.
Defiance Daily Target 2X Long HIMS ETF Company Profile
The Defiance Daily Target 2X Long HIMS ETF (HIMZ) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to deliver 2x leveraged exposure to the daily share price movement of Hims & Hers Health Inc (HIMS), less fees and expenses, through derivatives like swap agreements HIMZ was launched on Mar 12, 2025 and is issued by Defiance.
See Also
- Five stocks we like better than Defiance Daily Target 2X Long HIMS ETF
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for Defiance Daily Target 2X Long HIMS ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Defiance Daily Target 2X Long HIMS ETF and related companies with MarketBeat.com's FREE daily email newsletter.
